US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

5.77

+0.600011.61%

Post-market: 5.860.0900+1.56%19:59 EDT

Volume:4.88M

Turnover:28.13M

Market Cap:444.37M

PE:-4.31

High:6.05

Open:5.27

Low:5.26

Close:5.17

Loading ...

Overview Company News Filings

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025

Altimmune to Participate in the Citizens Life Sciences Conference

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Pfizer, Best Buy

BUZZ-Obesity drugmakers rise after Pfizer ends development of weight-loss pill

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Altimmune's US$42m Market Cap Fall Books Insider Losses

Simply Wall St.

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Altimmune Price Target Maintained With a $25.00/Share by Citizens Capital Markets

Altcoin Listings Spark Buzz in Crypto World

Coinbase to List ALT, PENDLE, and L3

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025

ALT Soars Over 18% Briefly Before Falling Back, Currently Trading at $0.038

Coinbase Adds ALT, PENDLE, and L3 to Asset Listing Roadmap

Press Release: MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":5.77,"timestamp":1746216000000,"preClose":5.17,"halted":0,"volume":4884189,"hourTrading":{"tag":"盘后","latestPrice":5.86,"preClose":5.77,"latestTime":"19:59 EDT","volume":77147,"amount":448984.8593,"timestamp":1746230374830},"delay":0,"floatShares":76335159,"shares":77013658,"eps":-1.338795,"marketStatus":"Market Closed","change":0.6,"latestTime":"05-02 16:00:00 EDT","open":5.27,"high":6.0486,"low":5.2601,"amount":28132946.2230804,"amplitude":0.152515,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.338795,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.17,"preHourTrading":{"tag":"盘前","latestPrice":5.27,"preClose":5.17,"latestTime":"09:28 EDT","volume":9871,"amount":51933.453265,"timestamp":1746192480097},"postHourTrading":{"tag":"盘后","latestPrice":5.86,"preClose":5.77,"latestTime":"19:59 EDT","volume":77147,"amount":448984.8593,"timestamp":1746230374830},"volumeRatio":2.939324790513276,"impliedVol":1.8358,"impliedVolPercentile":0.988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","floatShares":76335159,"roa":"-36.85%","roe":"-59.86%","lyrEps":-1.338795,"volumeRatio":2.939324790513276,"shares":77013658,"dividePrice":0,"high":6.0486,"amplitude":0.152515,"preClose":5.17,"low":5.2601,"week52Low":3.553,"pbRate":"3.60","psRate":"22218.44","week52High":11.16,"institutionHeld":0.7725,"latestPrice":5.77,"eps":-1.338795,"divideRate":0,"volume":4884189,"delay":0,"ttmEps":-1.338795,"open":5.27,"prevYearClose":7.21,"prevWeekClose":5.07,"prevMonthClose":5.25,"prevQuarterClose":5,"fiveDayClose":5.07,"twentyDayClose":4.46,"sixtyDayClose":6.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532076342","title":"Altimmune to Present at Upcoming EASL International Liver Congress™ 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532076342","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532076342?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:30","pubTimestamp":1746099000,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., May 01, 2025  -- Altimmune, Inc. , a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the Company will present analyses of pemvidutide-treated subjects with metabolic dysfunction-associated steatotic liver disease  utilizing the MASH Resolution Index , a highly sensitive non-invasive measure of MASH histologic response, in a poster session at the European Association for the Study of the Liver  International Liver Congress 2025 in Amsterdam, The Netherlands. The abstract will be featured in the conference poster session and poster tour.Session: MASLD: Therapy, Track Hub 7 – Metabolism, Alcohol, and Toxicity . A copy of the poster will be accessible on the Events section of the Altimmune website.About AltimmuneAltimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/altimmune-present-upcoming-easl-international-113000683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALT","BK4139","LU1878469433.USD","BK4599","ALD"],"gpt_icon":0},{"id":"2531035763","title":"Altimmune to Participate in the Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035763","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531035763?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter. This press release was published by a CLEAR Verified individual.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/altimmune-participate-citizens-life-sciences-113000648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ALT","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2531869477","title":"Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware","url":"https://stock-news.laohu8.com/highlight/detail?id=2531869477","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531869477?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:45","pubTimestamp":1745923500,"startTime":"0","endTime":"0","summary":"Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA. RAHWAY, N.J., April 29, 2025----Merck , known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware.A cornerstone of Merck’s continued commitment to investing in American innovation and infrastructure, Merck Wilmington Biotech will comprise laboratory, manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies including potent antibody-drug conjugates , reinforcing Merck’s focus on expanding and diversifying its pipeline.With proximity to Delaware and Pennsylvania universities, Merck Wilmington Biotech will also attract talented students and professionals, supporting community growth and development. The site’s proximity to Merck’s existing facilities ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/merck-breaks-ground-1-billion-104500898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1066053197.SGD","CRC","LU0965508806.USD","IE00BJT1NW94.SGD","LU1116320901.HKD","LU1585245621.USD","LU0320765646.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1066051498.USD","LU0122379950.USD","LU1035773651.USD","LU0965509010.AUD","LU1069347547.HKD","BK4588","BTC","CRT","LU0861579265.USD","LU1929549753.HKD","LU1066051811.HKD","MRK","ALT","BK4135","HCC","LU0265550946.USD","LU2468319806.SGD","BK4585","SG9999001440.SGD","LU0211331839.USD","CPS","LU0208291251.USD","LU1291159041.SGD","LU2361045086.USD","BCG","LU2324357040.USD","BK4161","LU1983299246.USD","DM","LU1974910355.USD","BK4559","RCC","IE00B4R5TH58.HKD","LU2023250504.SGD","HSCT","LU0965509283.SGD","LU1116320737.USD","SG9999002224.SGD","BK4533","SG9999015341.SGD","BK4516"],"gpt_icon":0},{"id":"2531266914","title":"GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266914","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531266914?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:10","pubTimestamp":1745871000,"startTime":"0","endTime":"0","summary":"Lille , Cambridge , Zurich , April 28, 2025 - GENFIT , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that Ipsen will be presenting data from its late-breaking abstract on elafibranor, highlighting favorable safety profile and significant efficacy in Primary Sclerosing Cholangitis , at the European Association for the Study of the Liver  on May 10, 2025 at 11.15 CET.Pascal Prigent, CEO of GENFIT, commented: “We continue to be very pleased with Ipsen’s commitment to developing elafibranor, and the results from the ELMWOOD Phase 2 trial further reinforce our belief in elafibranor’s potential to address serious liver diseases.”ABOUT PSCPSC is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, which can lead to liver damage and eventually liver failure. The exact cause of PSC is unknown, but it is often associated with other autoimmune conditions, such as inflam","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-positive-breaking-phase-2-201000577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GGT","PBC","ELF","BK4183","LU1559883803.SGD","BK4139","PSC","LU1242518931.SGD","GNFT","GNFTF","LU0566484027.USD","USA","BK4585","LU0979878070.USD","ALT","BK4201","EC","BK4599","LU1242518857.USD","LU1878469433.USD","CCA","LU0053671581.USD","BK4588"],"gpt_icon":0},{"id":"2530548354","title":"KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530548354","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530548354?lang=en_us&edition=fundamental","pubTime":"2025-04-28 00:00","pubTimestamp":1745769600,"startTime":"0","endTime":"0","summary":"KEYNOTE-689 marks the first positive trial in more than two decades for patients with resected locally advanced head and neck squamous cell carcinoma . Results to be presented at American Association for Cancer Research  Annual Meeting 2025 during a Plenary Session and included in official meeting press program. \"As the first positive trial in over two decades for patients with resectable, locally advanced head and neck squamous cell carcinoma, the presentation of these landmark results marks an important moment for these patients and those who care for them,\" said Dr. Ravindra Uppaluri, the study’s co-principal investigator, director of Head and Neck Surgical Oncology, Brigham and Women’s Hospital and Dana-Farber","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keytruda-pembrolizumab-perioperative-treatment-standard-160000135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALT","SG9999001440.SGD","SOC","LU1037948541.HKD","LU1430594728.SGD","AEIS","IE00BLSP4452.SGD","LU1934455194.USD","ITT","LU0054578231.USD","BK4135","BK4605","LU0320765646.SGD","OS","HSCT","CPS","LU1854103824.USD","LU2298322129.HKD","DM","LU2023250843.SGD","LU0320765489.SGD","LU1066051225.USD","HCC","BK4161","LU2361044865.SGD","BCG","LU1861220033.SGD","IE00BLSP4239.USD","SG9999014567.USD","MRK","RCC","IE0009355771.USD","LU2361044949.HKD","LU1162221912.USD","SMP","IE00BZ199S13.USD","ON","LU2106854487.HKD","LU0265550946.USD","BK4533","BK4097","CRT","LU0289739699.SGD","IE00B7SZL793.SGD","CRC","SG9999015358.SGD","LU0208291251.USD","SGXZ57979304.SGD","LU0861579265.USD","BTC"],"gpt_icon":0},{"id":"2529647669","title":"Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2529647669","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529647669?lang=en_us&edition=fundamental","pubTime":"2025-04-24 14:14","pubTimestamp":1745475240,"startTime":"0","endTime":"0","summary":"Elafibranor showed a favorable safety profile and demonstrated dose-dependent efficacy over 12 weeks for people living with PSC, a rare liver disease that currently has no approved treatment options. Patients treated with elafibranor versus placebo showed significant improvements in liver biochemical parameters, including alkaline phosphatase . Stabilization of non-invasive markers of liver fibrosis were observed in patients on elafibranor versus placebo. PARIS, FRANCE, 24 April 2025 Ipsen  will be presenting data from the late-breaking abstract on elafibranor in the investigational Phase II ELMWOOD study at the European Association for the Study of the Liver  congress as an oral presentation, on 10 May at 11.15 CET. For the first time data highlighting the potential of elafibranor in treating people living with primary sclerosing cholangitis  will be presented. PSC is a rare liver disease that currently has no approved treatment options.Patients on elafibranor also had stabilization i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/breaking-elafibranor-primary-sclerosing-cholangitis-061400283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","LU0566484027.USD","BK4139","ALT","LU0979878070.USD","BK4599","LU1242518931.SGD","LU1559883803.SGD","PSC","BK4585","ELF","EC","LU1242518857.USD","LU1878469433.USD","IPSEY","IPSEF","GGT","LU0053671581.USD","PBC","BK4201","BK4007","BK4588"],"gpt_icon":0},{"id":"2527590401","title":"BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Pfizer, Best Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2527590401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527590401?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:47","pubTimestamp":1744631225,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Pfizer, Best BuyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL6N3QS0HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU2552382132.HKD","VKTX","LU1582986433.USD","BBY","BULL","LU0354030511.USD","IE00BWXC8680.SGD","LU2430703251.USD","IE0004445239.USD","LU1720051108.HKD","LU2112291526.USD","LU0630314457.HKD","SGXZ57979304.SGD","LU0203347892.USD","ALT","LU0055631609.USD","SG9999015341.SGD","LU0612318971.USD","NEM","XOM","LU0417517546.SGD","PFE","SLB","LU1489326972.SGD","LU2750360997.AUD","LU1023059063.AUD","LU2087621335.USD","BK4585","LU1066051498.USD","LU1894683348.USD","LU0498741114.HKD","SGXZ23171101.USD","IE00BJT1NW94.SGD","LU0075056555.USD","CVX","IE00BLSP4239.USD","LU2592432038.USD","LU0820561909.HKD","LU0689472784.USD","BK4567","LU0320765646.SGD","GS","LU0368265764.SGD","SG9999014880.SGD","LU0912757837.SGD","LU0456854461.SGD","LU1720051017.SGD"],"gpt_icon":1},{"id":"2527153436","title":"BUZZ-Obesity drugmakers rise after Pfizer ends development of weight-loss pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2527153436","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527153436?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:15","pubTimestamp":1744629314,"startTime":"0","endTime":"0","summary":"BUZZ-Obesity drugmakers rise after Pfizer ends development of weight-loss pill** Shares of obesity drugmakers gain premarket after Pfizer PFE.N says it has discontinued development of experimental weight-loss pill danuglipron** Eli Lilly LLY.N shares up 1.69% to $744.82 in premarket trading, while U.S. listed shares of Danish drugmaker Novo Nordisk NOVOb.CO rise 3.74% to $67.15** Shares of obesity drug developer Viking Therapeutics VKTX.O jump 19.1% to $26.47, while Altimmune ALT.O rises 2.95% to $4.54** Pfizer shares down marginally at $21.75 before the bell** Up to last close, LLY down ~5%, VKTX down ~45%, while ALT down 39% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4N3QS0UF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","BK4533","LU1712237335.SGD","LU2361044865.SGD","LU0238689110.USD","LU0417517546.SGD","BK4592","LU0320765059.SGD","SG9999003800.SGD","BK4581","LU0823416689.USD","LU1974910355.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","LU1366192091.USD","LU1548497426.USD","IE0009355771.USD","IE00BLSP4452.SGD","PFE","SG9999015952.SGD","LU2602419157.SGD","LU1061106388.HKD","ALT","SG9999015986.USD","VKTX","LU2461242641.AUD","LU1023059063.AUD","BK4007","LU0256863902.USD","IE0004445239.USD","LU0882574139.USD","SGXZ31699556.SGD","LU2112291526.USD","SG9999017495.SGD","LU0708995401.HKD","LU2491050154.USD","LU0170899867.USD","LU0882574055.USD","SGXZ99366536.SGD","LU2237438978.USD","SG9999018865.SGD","LU1093756325.SGD","LU0109391861.USD","BK4585","LU1720051017.SGD","LU0106261372.USD","LU1814569148.SGD","IE00B19Z3B42.SGD","SG9999013999.USD"],"gpt_icon":1},{"id":"2527533581","title":"Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9","url":"https://stock-news.laohu8.com/highlight/detail?id=2527533581","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527533581?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/14/3060774/0/en/Verve-Therapeutics-Announces-Positive-Initial-Data-from-the-Heart-2-Phase-1b-Clinical-Trial-of-VERVE-102-an-In-Vivo-Base-Editing-Medicine-Targeting-PCSK9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNA","LU1169590202.USD","BK4505","LU1169589451.USD","VERV","BK4023","ALT","LU1878469433.USD","BK4588","BK4599","PD","BK4139","BK4585"],"gpt_icon":0},{"id":"2526638295","title":"Altimmune's US$42m Market Cap Fall Books Insider Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2526638295","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526638295?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:44","pubTimestamp":1744285445,"startTime":"0","endTime":"0","summary":"The recent price decline of 12% in Altimmune, Inc.'s  stock may have disappointed insiders who bought US$57.8k worth of shares at an average price of US$5.25 in the past 12 months. Insiders purchase with the hope of seeing their investments increase in value over time. However, due to recent losses, their initial investment is now only worth US$46.5k, which is not great.Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.The Last 12 Months Of Insider Transactions At Altimmune. In the last twelve months Altimmune insiders were buying shares, but not selling. The chart below shows insider transactions  over the last year. By clicking on the graph below, you can ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/altimmunes-us-42m-market-cap-114405522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1878469433.USD","BK4139","BK4599","ALT"],"gpt_icon":0},{"id":"2525198894","title":"Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2525198894","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525198894?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:31","pubTimestamp":1744115460,"startTime":"0","endTime":"0","summary":"WASHINGTON, D.C., April  08, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medici","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/08/3057618/0/en/Sixty-Degrees-Pharmaceuticals-Announces-Patent-License-Agreement-to-Advance-Development-of-Tafenoquine-for-Babesiosis-Treatment-and-Prevention-with-Yale-School-of-Medicine-and-Yale.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4139","LU1878469433.USD","BK4599","BK4007","SXTP"],"gpt_icon":0},{"id":"2525834416","title":"AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2525834416","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525834416?lang=en_us&edition=fundamental","pubTime":"2025-04-08 14:00","pubTimestamp":1744092000,"startTime":"0","endTime":"0","summary":"RINVOQ is the first and only oral Janus kinase  inhibitor approved in the European Union  to treat adult patients with giant cell arteritis . The approval is supported by data from the pivotal Phase 3 SELECT-GCA trial which demonstrated that RINVOQ achieved the primary endpoint of sustained remission* and key secondary endpoints, including reduction in disease flares, lower cumulative steroid exposure and complete remission 1. This marks the eighth approved indication for RINVOQ in the EU2. NORTH CHICAGO, Ill., April 8, 2025 /PRNewswire/ -- AbbVie  today announced that the European Commission  granted marketing authorization to RINVOQ  for the treatment of giant cell arteritis  in adult patients. RINVOQ is the first and only oral JAK inhibitor approved in the EU, as well as Iceland, Liechtenstein and Norway, for the treatment of adult patients with GCA.GCAis an autoimmune disease that causes inflammation of the temporal and other cranial arteries, the aorta, and other large and medium ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/abbvie-announces-european-commission-approval-060000872.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abbvie-announces-european-commission-approval-060000872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1551013342.USD","LU0861579265.USD","CPK","SG9999015945.SGD","LU0234570918.USD","IE0009355771.USD","IE00B42XCP33.USD","LU2129689431.USD","LU2237443978.SGD","LU0211327993.USD","LU2237443622.USD","LU1093756168.USD","LU1003077747.HKD","TAK","IE0004445239.USD","LU1878469433.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","LU1061106388.HKD","LU0456855351.SGD","LU0965508806.USD","LU0198837287.USD","LU1093756325.SGD","LU1162221912.USD","LU2237443895.HKD","SG9999015978.USD","BK4139","SG9999015986.USD","BK4559","LU2237443465.HKD","IE00B2B36J28.USD","LU0965509101.SGD","LU2087621335.USD","BK4156","LU0320765646.SGD","LU1551013425.SGD","RA","IE00BVYPNV92.GBP","LU2023251221.USD","EC","LU1718418525.SGD","BK4007","ALT","LU1037948897.HKD","LU1934455194.USD","LU0211328371.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","ABBV"],"gpt_icon":0},{"id":"2524166296","title":"Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524166296","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524166296?lang=en_us&edition=fundamental","pubTime":"2025-04-04 01:22","pubTimestamp":1743700920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 13:22 ET (17:22 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2524703490","title":"Altimmune Price Target Maintained With a $25.00/Share by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2524703490","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524703490?lang=en_us&edition=fundamental","pubTime":"2025-04-02 23:13","pubTimestamp":1743606780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 11:13 ET (15:13 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2522334487","title":"Altcoin Listings Spark Buzz in Crypto World","url":"https://stock-news.laohu8.com/highlight/detail?id=2522334487","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522334487?lang=en_us&edition=fundamental","pubTime":"2025-03-27 02:39","pubTimestamp":1743014363,"startTime":"0","endTime":"0","summary":"You can also read this news on BH NEWS: Altcoin Listings Spark Buzz in Crypto World. The cryptocurrency market is buzzing with excitement as exchanges roll out new altcoin listings, setting high expectations for the coming months. The recent inclusion of specific altcoins on various platforms aligns with the anticipated roadmap updates from exchanges. Just a short time ago, one prominent exchange confirmed an imminent listing, fueling further enthusiasm.The Coinbase exchange has revealed plans to support AltLayer , Pendle , and Layer3 . These altcoins, which had previously been mentioned in upcoming listings, are now officially set to be added to the exchange.In the backdrop of these developments, other significant news has surfaced. Senior officials in the EU hinted that former President Trump may consider imposing tariffs of approximately 20%, leading to a drop in Bitcoin prices. Concerns have arisen regarding potential negative impacts on consumer confidence, with Fed member Kashkar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67e449de1ae0cc00199f5ad3/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["TON.USD.HKCC","TON.USD.CC","BK4139","LU1878469433.USD","APT.USD.CC","APT.USD.HKCC","BK4599","ALT"],"gpt_icon":0},{"id":"2522331338","title":"Coinbase to List ALT, PENDLE, and L3","url":"https://stock-news.laohu8.com/highlight/detail?id=2522331338","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522331338?lang=en_us&edition=fundamental","pubTime":"2025-03-27 02:22","pubTimestamp":1743013320,"startTime":"0","endTime":"0","summary":"BlockBeats News, March 27th, Coinbase will add support for AltLayer , Pendle , and Layer3  on the Ethereum network . If liquidity conditions are met, trading will begin on March 27, 2025, at 9:00 AM Pacific Time or later. Once an adequate supply of these assets is available, the ALT-USD, PENDLE-USD, and L3-USD trading pairs will be phased in.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/287133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["03179","BK4599","09046","ERC","FETH","ALT","EZET","03046","ETHV","BK4144","09179","LU1878469433.USD","LDO.USD.HKCC","03009","BK4139","QETH","ETH.USD.HKCC","USD","CETH","COIN","09009","ETH.USD.CC","AM"],"gpt_icon":0},{"id":"2521747128","title":"Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747128","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747128?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:00","pubTimestamp":1742817600,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, CALIF., March 24, 2025----Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that it will present topline results from the PORTOLA Phase 2a trial evaluating zetomipzomib for the treatment of patients with autoimmune hepatitis  on Tuesday, March 25, 2025, at 8:00 a.m. ET.The event will highlight topline data from Kezar’s PORTOLA trial, a placebo-controlled, randomized, double-blind Phase 2a clinical trial evaluating the efficacy and safety of zetomipzomib in patients with AIH. Additionally, the event will feature presentations from Craig Lammert, MD, Associate Professor of Medicine at Indiana University School of Medicine and a principal investigator on the PORTOLA trial, and Gideon Hirschfield, PhD, the Lily and Terry Horner Chair in Autoimmune Liver Disease Research, and Director of the Francis Family Liver Clinic at Toronto General Hospit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kezar-life-sciences-present-topline-120000618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","AIH","KZR","BK4139","BK4599","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2521849875","title":"ALT Soars Over 18% Briefly Before Falling Back, Currently Trading at $0.038","url":"https://stock-news.laohu8.com/highlight/detail?id=2521849875","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521849875?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:54","pubTimestamp":1742496840,"startTime":"0","endTime":"0","summary":"BlockBeats News, March 21st, possibly influenced by the news of \"Coinbase to Add AltLayer (ALT) to Asset Listing Roadmap,\" ALT surged over 18% briefly before falling back, currently trading at $0.038.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/286438","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2521930734","title":"Coinbase Adds ALT, PENDLE, and L3 to Asset Listing Roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=2521930734","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521930734?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:53","pubTimestamp":1742496780,"startTime":"0","endTime":"0","summary":"BlockBeats News, March 21, Coinbase will add AltLayer (ALT), Pendle (PENDLE), and Layer3 (L3) to its asset listing roadmap.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/286437","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4585","BK4599","ALT","BK4112","BK4551","BK4554","BK4588","BK4596","BK4535","COIN","LU1861558580.USD","LU1861559042.SGD","BK4139","LU1878469433.USD","BK4539","BK4600","BK4595","BK4516"],"gpt_icon":0},{"id":"2520458331","title":"Press Release: MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520458331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520458331?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:31","pubTimestamp":1742470260,"startTime":"0","endTime":"0","summary":"Top-Line Data From MAD Part 2 of the Phase 1 Trial of DA-1726 Expected in April of 2025. Announced Positive Top-Line 16-Week Results from the Phase 2a Trial of DA-1241 for the Treatment of MASH, in December, Demonstrating Direct Hepatic Action in Addition to Its Glucose Lowering Effect. $16.0 Million in Cash at End of Fourth Quarter Expected to Fund the Company Into the Third Quarter of 2025. CAMBRIDGE, Mass., March 20, 2025 /PRNewswire/ -- MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2024 and provided a corporate strategic update.Mr. Kim continued, \"In December, we reported positive top-line 16-week results from the two-part Phase 2a clinical trial of DA-1241, a novel G-Protein-Coupled Receptor 119  agonist, in patients with presumed metabolic dysfunction-associated steatohepatitis . DA-1241 met the primary endpoint, achieving a reduction in alanine transaminase","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA","BK4599","OXM","BK4202","LU1878469433.USD","ALT","GGT"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"ALT","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-11-12","symbol":"ALT","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-08-08","symbol":"ALT","fiscalQuarterEnding":"2024/06","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-05-09","symbol":"ALT","fiscalQuarterEnding":"2024/03","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-03-27","symbol":"ALT","fiscalQuarterEnding":"2023/12","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711512000000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1740715200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALT","date":"2025-05-02","current":-4.188563,"percent":0.727864,"low":-46.273572,"twenty":-9.229315,"median":-5.62647,"eighty":-3.213748,"high":-1.406077,"avg":-6.782781,"sd":5.453757,"marketCap":398160611},"quantilePoints":[{"date":"2020-05-08","current":-2.292473,"twenty":-1.256747,"median":-0.842537,"eighty":-0.527524,"marketCap":47041841},{"date":"2020-05-15","current":-3.074859,"twenty":-1.270658,"median":-0.844262,"eighty":-0.532381,"marketCap":68595403},{"date":"2020-05-22","current":-4.770149,"twenty":-1.345551,"median":-0.844264,"eighty":-0.535619,"marketCap":106414744},{"date":"2020-05-29","current":-6.36935,"twenty":-1.937182,"median":-0.851156,"eighty":-0.536619,"marketCap":142090478},{"date":"2020-06-05","current":-8.54727,"twenty":-2.211389,"median":-0.854597,"eighty":-0.538199,"marketCap":190676543},{"date":"2020-06-12","current":-8.524658,"twenty":-2.245297,"median":-0.858043,"eighty":-0.538857,"marketCap":190172108},{"date":"2020-06-19","current":-8.366375,"twenty":-2.282153,"median":-0.861395,"eighty":-0.539667,"marketCap":186641061},{"date":"2020-06-26","current":-11.984267,"twenty":-2.31901,"median":-0.864935,"eighty":-0.540746,"marketCap":267350709},{"date":"2020-07-02","current":-11.780761,"twenty":-2.329329,"median":-0.871046,"eighty":-0.542905,"marketCap":262810791},{"date":"2020-07-10","current":-25.268714,"twenty":-2.37798,"median":-0.876338,"eighty":-0.546142,"marketCap":563706447},{"date":"2020-07-17","current":-39.87374,"twenty":-2.464961,"median":-0.882047,"eighty":-0.551269,"marketCap":889522282},{"date":"2020-07-24","current":-35.658198,"twenty":-2.511587,"median":-0.882106,"eighty":-0.555317,"marketCap":795479975},{"date":"2020-07-31","current":-36.979902,"twenty":-2.577308,"median":-0.889057,"eighty":-0.558825,"marketCap":824965187},{"date":"2020-08-07","current":-38.092917,"twenty":-2.657548,"median":-0.893652,"eighty":-0.56016,"marketCap":849794839},{"date":"2020-08-14","current":-22.525667,"twenty":-2.805189,"median":-0.898031,"eighty":-0.561197,"marketCap":803907295},{"date":"2020-08-21","current":-21.96438,"twenty":-2.869381,"median":-0.902327,"eighty":-0.561253,"marketCap":783875813},{"date":"2020-08-28","current":-16.098684,"twenty":-2.956041,"median":-0.905258,"eighty":-0.561524,"marketCap":574537930},{"date":"2020-09-04","current":-11.35679,"twenty":-3.087213,"median":-0.907254,"eighty":-0.563087,"marketCap":405306837},{"date":"2020-09-11","current":-11.046146,"twenty":-3.177503,"median":-0.908968,"eighty":-0.565026,"marketCap":394220407},{"date":"2020-09-18","current":-12.900875,"twenty":-3.305887,"median":-0.909901,"eighty":-0.568591,"marketCap":460412915},{"date":"2020-09-25","current":-11.804484,"twenty":-3.450319,"median":-0.915777,"eighty":-0.568832,"marketCap":421284339},{"date":"2020-10-02","current":-11.850167,"twenty":-3.626847,"median":-0.919185,"eighty":-0.56887,"marketCap":422914696},{"date":"2020-10-09","current":-11.301971,"twenty":-4.67722,"median":-0.919185,"eighty":-0.570264,"marketCap":403350408},{"date":"2020-10-16","current":-11.850167,"twenty":-4.848628,"median":-0.928329,"eighty":-0.572047,"marketCap":422914696},{"date":"2020-10-23","current":-10.963917,"twenty":-5.046072,"median":-0.930791,"eighty":-0.572259,"marketCap":391285764},{"date":"2020-10-30","current":-10.461404,"twenty":-5.241612,"median":-0.937755,"eighty":-0.572714,"marketCap":373351833},{"date":"2020-11-06","current":-11.375064,"twenty":-5.335212,"median":-0.937755,"eighty":-0.576558,"marketCap":405958980},{"date":"2020-11-13","current":-7.837321,"twenty":-5.405412,"median":-0.941735,"eighty":-0.580401,"marketCap":333237614},{"date":"2020-11-20","current":-7.210645,"twenty":-5.429046,"median":-0.942397,"eighty":-0.581491,"marketCap":306591763},{"date":"2020-11-27","current":-8.139054,"twenty":-5.509728,"median":-0.943742,"eighty":-0.583694,"marketCap":346067098},{"date":"2020-12-04","current":-9.539405,"twenty":-5.616013,"median":-0.94704,"eighty":-0.584245,"marketCap":405609060},{"date":"2020-12-11","current":-9.260882,"twenty":-5.690893,"median":-0.956324,"eighty":-0.58732,"marketCap":393766460},{"date":"2020-12-18","current":-9.647719,"twenty":-5.791553,"median":-0.957434,"eighty":-0.588089,"marketCap":410214516},{"date":"2020-12-24","current":-8.858572,"twenty":-5.840973,"median":-0.958492,"eighty":-0.589596,"marketCap":376660482},{"date":"2020-12-31","current":-9.807293,"twenty":-5.850013,"median":-0.965609,"eighty":-0.590601,"marketCap":416999468},{"date":"2021-01-08","current":-12.276505,"twenty":-5.920213,"median":-0.96954,"eighty":-0.591133,"marketCap":521988696},{"date":"2021-01-15","current":-11.24187,"twenty":-6.051347,"median":-0.974894,"eighty":-0.591932,"marketCap":477996731},{"date":"2021-01-22","current":-12.476476,"twenty":-6.084014,"median":-0.976283,"eighty":-0.592399,"marketCap":530491345},{"date":"2021-01-29","current":-12.415615,"twenty":-6.19479,"median":-0.981857,"eighty":-0.595339,"marketCap":527903582},{"date":"2021-02-05","current":-15.962934,"twenty":-6.336734,"median":-0.985303,"eighty":-0.59962,"marketCap":678733177},{"date":"2021-02-12","current":-19.318976,"twenty":-7.087016,"median":-0.988821,"eighty":-0.59962,"marketCap":821429804},{"date":"2021-02-19","current":-19.936279,"twenty":-7.210645,"median":-0.990004,"eighty":-0.59962,"marketCap":847677111},{"date":"2021-02-26","current":-12.019122,"twenty":-7.357643,"median":-0.992005,"eighty":-0.59962,"marketCap":589471561},{"date":"2021-03-05","current":-9.757054,"twenty":-7.837321,"median":-0.998372,"eighty":-0.603077,"marketCap":478529611},{"date":"2021-03-12","current":-12.637421,"twenty":-8.231895,"median":-1.002367,"eighty":-0.603464,"marketCap":619795694},{"date":"2021-03-19","current":-12.381053,"twenty":-8.510418,"median":-1.005411,"eighty":-0.603464,"marketCap":607222273},{"date":"2021-03-26","current":-10.443215,"twenty":-8.587786,"median":-1.00739,"eighty":-0.605274,"marketCap":512182002},{"date":"2021-04-01","current":-10.556318,"twenty":-8.78138,"median":-1.016675,"eighty":-0.605274,"marketCap":517729100},{"date":"2021-04-09","current":-9.726893,"twenty":-9.292271,"median":-1.021158,"eighty":-0.6069,"marketCap":477050385},{"date":"2021-04-16","current":-9.251859,"twenty":-9.464501,"median":-1.024724,"eighty":-0.607307,"marketCap":453752575},{"date":"2021-04-23","current":-9.380043,"twenty":-9.464501,"median":-1.029527,"eighty":-0.607307,"marketCap":460039286},{"date":"2021-04-30","current":-10.910709,"twenty":-9.499174,"median":-1.032222,"eighty":-0.607307,"marketCap":535110005},{"date":"2021-05-07","current":-10.005881,"twenty":-9.568548,"median":-1.035738,"eighty":-0.608615,"marketCap":490733225},{"date":"2021-05-14","current":-10.088824,"twenty":-9.690182,"median":-1.043356,"eighty":-0.610709,"marketCap":494801097},{"date":"2021-05-21","current":-8.930849,"twenty":-9.656014,"median":-1.045001,"eighty":-0.612319,"marketCap":536054794},{"date":"2021-05-28","current":-8.0639,"twenty":-9.614543,"median":-1.047082,"eighty":-0.613503,"marketCap":484018069},{"date":"2021-06-04","current":-8.255139,"twenty":-9.601725,"median":-1.054534,"eighty":-0.614487,"marketCap":495496759},{"date":"2021-06-11","current":-9.160335,"twenty":-9.601725,"median":-1.060147,"eighty":-0.617301,"marketCap":549829222},{"date":"2021-06-18","current":-10.18665,"twenty":-9.645972,"median":-1.061987,"eighty":-0.619095,"marketCap":611431522},{"date":"2021-06-25","current":-10.250396,"twenty":-9.735941,"median":-1.064048,"eighty":-0.619675,"marketCap":615257751},{"date":"2021-07-02","current":-5.953899,"twenty":-9.75253,"median":-1.073166,"eighty":-0.622777,"marketCap":357369863},{"date":"2021-07-09","current":-5.871029,"twenty":-9.740466,"median":-1.078488,"eighty":-0.625409,"marketCap":352395764},{"date":"2021-07-16","current":-5.603295,"twenty":-9.713792,"median":-1.081387,"eighty":-0.626526,"marketCap":336325599},{"date":"2021-07-23","current":-5.660666,"twenty":-9.692161,"median":-1.084345,"eighty":-0.626829,"marketCap":339769206},{"date":"2021-07-30","current":-5.781784,"twenty":-9.672603,"median":-1.09804,"eighty":-0.627284,"marketCap":347039042},{"date":"2021-08-06","current":-6.53399,"twenty":-9.646554,"median":-1.106702,"eighty":-0.627284,"marketCap":392188554},{"date":"2021-08-13","current":-6.989861,"twenty":-9.629384,"median":-1.114155,"eighty":-0.627315,"marketCap":475890082},{"date":"2021-08-20","current":-7.373664,"twenty":-9.603233,"median":-1.117881,"eighty":-0.628565,"marketCap":502020486},{"date":"2021-08-27","current":-8.542517,"twenty":-9.583629,"median":-1.12906,"eighty":-0.630603,"marketCap":581599443},{"date":"2021-09-03","current":-9.554361,"twenty":-9.558349,"median":-1.132786,"eighty":-0.630952,"marketCap":650488690},{"date":"2021-09-10","current":-9.775338,"twenty":-9.591169,"median":-1.136512,"eighty":-0.630952,"marketCap":665533468},{"date":"2021-09-17","current":-8.862353,"twenty":-9.605176,"median":-1.137989,"eighty":-0.631686,"marketCap":603374780},{"date":"2021-09-24","current":-8.705343,"twenty":-9.600447,"median":-1.155144,"eighty":-0.635355,"marketCap":592685069},{"date":"2021-10-01","current":-6.949155,"twenty":-9.591169,"median":-1.16462,"eighty":-0.638289,"marketCap":473118675},{"date":"2021-10-08","current":-7.077089,"twenty":-9.559679,"median":-1.173775,"eighty":-0.638289,"marketCap":481828810},{"date":"2021-10-15","current":-6.984046,"twenty":-9.554182,"median":-1.181272,"eighty":-0.638815,"marketCap":475494167},{"date":"2021-10-22","current":-6.699101,"twenty":-9.550655,"median":-1.192207,"eighty":-0.641115,"marketCap":456094321},{"date":"2021-10-29","current":-6.280407,"twenty":-9.538907,"median":-1.192406,"eighty":-0.641912,"marketCap":427588426},{"date":"2021-11-05","current":-6.303668,"twenty":-9.536915,"median":-1.195875,"eighty":-0.642691,"marketCap":429172087},{"date":"2021-11-12","current":-5.254536,"twenty":-9.534318,"median":-1.207066,"eighty":-0.645626,"marketCap":440449772},{"date":"2021-11-19","current":-4.989681,"twenty":-9.517742,"median":-1.21849,"eighty":-0.645626,"marketCap":418248884},{"date":"2021-11-26","current":-4.928196,"twenty":-9.492985,"median":-1.222217,"eighty":-0.645626,"marketCap":413095106},{"date":"2021-12-03","current":-4.483618,"twenty":-9.492985,"median":-1.234811,"eighty":-0.645626,"marketCap":375829329},{"date":"2021-12-10","current":-4.455241,"twenty":-9.478066,"median":-1.237122,"eighty":-0.645626,"marketCap":373450662},{"date":"2021-12-17","current":-4.426864,"twenty":-9.474354,"median":-1.242711,"eighty":-0.645626,"marketCap":371071995},{"date":"2021-12-23","current":-4.351191,"twenty":-9.464501,"median":-1.250163,"eighty":-0.64856,"marketCap":364728884},{"date":"2021-12-31","current":-4.332272,"twenty":-9.444757,"median":-1.266932,"eighty":-0.649294,"marketCap":363143107},{"date":"2022-01-07","current":-3.916072,"twenty":-9.429228,"median":-1.270658,"eighty":-0.649294,"marketCap":328255996},{"date":"2022-01-14","current":-3.707971,"twenty":-9.419545,"median":-1.300468,"eighty":-0.649294,"marketCap":310812440},{"date":"2022-01-21","current":-3.305959,"twenty":-9.395156,"median":-1.357281,"eighty":-0.649294,"marketCap":277114663},{"date":"2022-01-28","current":-3.40528,"twenty":-9.375518,"median":-1.896273,"eighty":-0.649294,"marketCap":285439996},{"date":"2022-02-04","current":-3.622839,"twenty":-9.356009,"median":-2.181903,"eighty":-0.649294,"marketCap":303676441},{"date":"2022-02-11","current":-3.632298,"twenty":-9.294535,"median":-2.226131,"eighty":-0.651495,"marketCap":304469329},{"date":"2022-02-18","current":-3.339066,"twenty":-9.255468,"median":-2.240874,"eighty":-0.652962,"marketCap":279889774},{"date":"2022-02-25","current":-3.599191,"twenty":-9.25041,"median":-2.262988,"eighty":-0.65443,"marketCap":301694218},{"date":"2022-03-04","current":-3.277582,"twenty":-9.216158,"median":-2.281416,"eighty":-0.656631,"marketCap":274735996},{"date":"2022-03-11","current":-3.29177,"twenty":-9.164959,"median":-2.299844,"eighty":-0.656631,"marketCap":275925330},{"date":"2022-03-18","current":-3.187041,"twenty":-9.152685,"median":-2.321958,"eighty":-0.656631,"marketCap":309429796},{"date":"2022-03-25","current":-2.824576,"twenty":-9.120812,"median":-2.329329,"eighty":-0.656889,"marketCap":274238058},{"date":"2022-04-01","current":-2.749431,"twenty":-9.069815,"median":-2.351443,"eighty":-0.658485,"marketCap":266942209},{"date":"2022-04-08","current":-2.510734,"twenty":-9.026468,"median":-2.395671,"eighty":-0.660299,"marketCap":243767162},{"date":"2022-04-14","current":-2.31182,"twenty":-9.002244,"median":-2.403042,"eighty":-0.660299,"marketCap":224454623},{"date":"2022-04-22","current":-2.006819,"twenty":-8.981208,"median":-2.373557,"eighty":-0.660299,"marketCap":194842063},{"date":"2022-04-29","current":-1.997978,"twenty":-8.97802,"median":-2.3367,"eighty":-0.660463,"marketCap":193983728},{"date":"2022-05-06","current":-1.913993,"twenty":-8.974196,"median":-2.325643,"eighty":-0.661689,"marketCap":185829544},{"date":"2022-05-13","current":-2.19104,"twenty":-8.962867,"median":-2.314587,"eighty":-0.663967,"marketCap":222734186},{"date":"2022-05-20","current":-2.131593,"twenty":-8.93653,"median":-2.296159,"eighty":-0.664701,"marketCap":216691010},{"date":"2022-05-27","current":-2.13584,"twenty":-8.925681,"median":-2.280878,"eighty":-0.66787,"marketCap":217122666},{"date":"2022-06-03","current":-2.309934,"twenty":-8.905008,"median":-2.27773,"eighty":-0.668807,"marketCap":234820537},{"date":"2022-06-10","current":-3.630503,"twenty":-8.886226,"median":-2.28299,"eighty":-0.668883,"marketCap":369065367},{"date":"2022-06-17","current":-3.830074,"twenty":-8.882388,"median":-2.299844,"eighty":-0.671304,"marketCap":389353170},{"date":"2022-06-24","current":-4.369342,"twenty":-8.86636,"median":-2.31182,"eighty":-0.671304,"marketCap":444173406},{"date":"2022-07-01","current":-4.781223,"twenty":-8.859328,"median":-2.321958,"eighty":-0.671304,"marketCap":486043980},{"date":"2022-07-08","current":-5.379938,"twenty":-8.843395,"median":-2.329329,"eighty":-0.672112,"marketCap":546907391},{"date":"2022-07-15","current":-4.810947,"twenty":-8.833277,"median":-2.3367,"eighty":-0.673733,"marketCap":489065568},{"date":"2022-07-22","current":-5.554032,"twenty":-8.79056,"median":-2.3883,"eighty":-0.674765,"marketCap":564605263},{"date":"2022-07-29","current":-5.099688,"twenty":-8.752462,"median":-2.431168,"eighty":-0.674972,"marketCap":518418135},{"date":"2022-08-05","current":-5.26529,"twenty":-8.743932,"median":-2.458327,"eighty":-0.677129,"marketCap":535252696},{"date":"2022-08-12","current":-8.685942,"twenty":-8.727192,"median":-2.479782,"eighty":-0.678611,"marketCap":841987671},{"date":"2022-08-19","current":-8.585874,"twenty":-8.767651,"median":-2.479782,"eighty":-0.678611,"marketCap":832287353},{"date":"2022-08-26","current":-9.231316,"twenty":-8.857064,"median":-2.479782,"eighty":-0.678611,"marketCap":894854409},{"date":"2022-09-02","current":-11.212671,"twenty":-8.915344,"median":-2.479782,"eighty":-0.678611,"marketCap":1086920721},{"date":"2022-09-09","current":-9.996839,"twenty":-8.976745,"median":-2.479782,"eighty":-0.678611,"marketCap":969061848},{"date":"2022-09-16","current":-6.839679,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":663016789},{"date":"2022-09-23","current":-6.189234,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":599964717},{"date":"2022-09-30","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-10-07","current":-5.28636,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":512442952},{"date":"2022-10-14","current":-5.256037,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":509503508},{"date":"2022-10-21","current":-5.422815,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525670447},{"date":"2022-10-28","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-11-04","current":-5.983796,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":580050148},{"date":"2022-11-11","current":-6.042666,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525366485},{"date":"2022-11-18","current":-4.996929,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":434447121},{"date":"2022-11-25","current":-5.138245,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":446733522},{"date":"2022-12-02","current":-6.376172,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":554362390},{"date":"2022-12-09","current":-5.709161,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":496370580},{"date":"2022-12-16","current":-6.489225,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":564191510},{"date":"2022-12-23","current":-8.665489,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":753402078},{"date":"2022-12-30","current":-9.298584,"twenty":-9.046009,"median":-2.479782,"eighty":-0.678611,"marketCap":808445152},{"date":"2023-01-06","current":-8.077615,"twenty":-9.046009,"median":-2.550468,"eighty":-0.678611,"marketCap":702290652},{"date":"2023-01-13","current":-9.208142,"twenty":-9.082964,"median":-2.674285,"eighty":-0.678611,"marketCap":800581856},{"date":"2023-01-20","current":-8.111531,"twenty":-9.082964,"median":-2.74501,"eighty":-0.678611,"marketCap":705239388},{"date":"2023-01-27","current":-7.478436,"twenty":-9.082964,"median":-2.834635,"eighty":-0.678611,"marketCap":650196314},{"date":"2023-02-03","current":-8.569394,"twenty":-9.082964,"median":-3.041104,"eighty":-0.682837,"marketCap":745047326},{"date":"2023-02-10","current":-7.591488,"twenty":-9.082964,"median":-3.089794,"eighty":-0.692599,"marketCap":660025434},{"date":"2023-02-17","current":-6.760551,"twenty":-9.082964,"median":-3.29177,"eighty":-0.706713,"marketCap":587781399},{"date":"2023-02-24","current":-6.771856,"twenty":-9.082964,"median":-3.329607,"eighty":-0.719867,"marketCap":588764311},{"date":"2023-03-03","current":-6.742082,"twenty":-9.082964,"median":-3.358746,"eighty":-0.742102,"marketCap":571141998},{"date":"2023-03-10","current":-6.032389,"twenty":-9.082964,"median":-3.414739,"eighty":-0.768114,"marketCap":511021788},{"date":"2023-03-17","current":-6.404687,"twenty":-9.082964,"median":-3.495141,"eighty":-0.78253,"marketCap":542560259},{"date":"2023-03-24","current":-2.513011,"twenty":-9.082964,"median":-3.5046,"eighty":-0.796016,"marketCap":212884679},{"date":"2023-03-31","current":-2.454839,"twenty":-9.080548,"median":-3.499871,"eighty":-0.802556,"marketCap":207956793},{"date":"2023-04-06","current":-2.251239,"twenty":-9.080548,"median":-3.499871,"eighty":-0.804482,"marketCap":190709192},{"date":"2023-04-14","current":-2.681708,"twenty":-9.082964,"median":-3.5046,"eighty":-0.809804,"marketCap":227175549},{"date":"2023-04-21","current":-3.33323,"twenty":-9.082964,"median":-3.5046,"eighty":-0.816048,"marketCap":282367873},{"date":"2023-04-28","current":-2.885309,"twenty":-9.085381,"median":-3.51872,"eighty":-0.82152,"marketCap":244423150},{"date":"2023-05-05","current":-2.873674,"twenty":-9.085381,"median":-3.51872,"eighty":-0.831857,"marketCap":243437573},{"date":"2023-05-12","current":-3.100543,"twenty":-9.085381,"median":-3.51872,"eighty":-0.840814,"marketCap":262656329},{"date":"2023-05-19","current":-2.569103,"twenty":-9.085381,"median":-3.51872,"eighty":-0.844264,"marketCap":219290931},{"date":"2023-05-26","current":-2.431202,"twenty":-9.085381,"median":-3.51872,"eighty":-0.854355,"marketCap":207520115},{"date":"2023-06-02","current":-2.396553,"twenty":-9.085381,"median":-3.51872,"eighty":-0.858045,"marketCap":204562584},{"date":"2023-06-09","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.86619,"marketCap":201605053},{"date":"2023-06-16","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.879261,"marketCap":201605053},{"date":"2023-06-23","current":-2.402328,"twenty":-9.087797,"median":-3.53284,"eighty":-0.88307,"marketCap":205055506},{"date":"2023-06-30","current":-2.021189,"twenty":-9.090214,"median":-3.532909,"eighty":-0.895974,"marketCap":172522661},{"date":"2023-07-07","current":-1.940342,"twenty":-9.090214,"median":-3.532909,"eighty":-0.899395,"marketCap":165621755},{"date":"2023-07-14","current":-1.957666,"twenty":-9.090214,"median":-3.532909,"eighty":-0.906287,"marketCap":167100520},{"date":"2023-07-21","current":-1.836395,"twenty":-9.090214,"median":-3.532909,"eighty":-0.909901,"marketCap":156749161},{"date":"2023-07-28","current":-1.726673,"twenty":-9.090214,"median":-3.532909,"eighty":-0.919185,"marketCap":147383645},{"date":"2023-08-04","current":-1.795971,"twenty":-9.090214,"median":-3.532909,"eighty":-0.928329,"marketCap":153298707},{"date":"2023-08-11","current":-1.969804,"twenty":-9.090214,"median":-3.532909,"eighty":-0.937755,"marketCap":160166735},{"date":"2023-08-18","current":-1.743017,"twenty":-9.090214,"median":-3.532909,"eighty":-0.941735,"marketCap":141726485},{"date":"2023-08-25","current":-1.587507,"twenty":-9.090214,"median":-3.532909,"eighty":-0.945086,"marketCap":129081743},{"date":"2023-09-01","current":-1.639343,"twenty":-9.090214,"median":-3.532909,"eighty":-0.956324,"marketCap":133296657},{"date":"2023-09-08","current":-1.593986,"twenty":-9.090214,"median":-3.532909,"eighty":-0.958492,"marketCap":129608607},{"date":"2023-09-15","current":-1.807814,"twenty":-9.090214,"median":-3.532909,"eighty":-0.970251,"marketCap":146995128},{"date":"2023-09-22","current":-1.658782,"twenty":-9.090214,"median":-3.532909,"eighty":-0.979536,"marketCap":134877250},{"date":"2023-09-29","current":-1.619905,"twenty":-9.090214,"median":-3.532909,"eighty":-0.985303,"marketCap":131716065},{"date":"2023-10-06","current":-1.684701,"twenty":-9.090214,"median":-3.532909,"eighty":-0.991188,"marketCap":136984707},{"date":"2023-10-13","current":-1.69118,"twenty":-9.090214,"median":-3.532909,"eighty":-1.00206,"marketCap":137511571},{"date":"2023-10-20","current":-1.509751,"twenty":-9.090214,"median":-3.532909,"eighty":-1.006093,"marketCap":122759372},{"date":"2023-10-27","current":-1.503271,"twenty":-9.120812,"median":-3.537707,"eighty":-1.019689,"marketCap":122232508},{"date":"2023-11-03","current":-1.658782,"twenty":-9.120812,"median":-3.537707,"eighty":-1.028451,"marketCap":134877250},{"date":"2023-11-10","current":-1.677615,"twenty":-9.120812,"median":-3.537707,"eighty":-1.034911,"marketCap":131635733},{"date":"2023-11-17","current":-1.615988,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":126800135},{"date":"2023-11-24","current":-1.924122,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":150978127},{"date":"2023-12-01","current":-2.163781,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":169783232},{"date":"2023-12-08","current":-4.505594,"twenty":-9.110613,"median":-3.544802,"eighty":-1.035771,"marketCap":353535971},{"date":"2023-12-15","current":-4.793186,"twenty":-9.110613,"median":-3.60865,"eighty":-1.041865,"marketCap":376102097},{"date":"2023-12-22","current":-5.402605,"twenty":-9.110613,"median":-3.686688,"eighty":-1.046438,"marketCap":423920792},{"date":"2023-12-29","current":-7.956688,"twenty":-9.120812,"median":-3.745808,"eighty":-1.059015,"marketCap":624329481},{"date":"2024-01-05","current":-8.00462,"twenty":-9.131012,"median":-3.795468,"eighty":-1.062066,"marketCap":628090501},{"date":"2024-01-12","current":-7.867672,"twenty":-9.131012,"median":-3.884844,"eighty":-1.073911,"marketCap":617344727},{"date":"2024-01-19","current":-7.388353,"twenty":-9.141211,"median":-4.008415,"eighty":-1.078488,"marketCap":579734518},{"date":"2024-01-26","current":-6.354395,"twenty":-9.131012,"median":-4.119442,"eighty":-1.078619,"marketCap":498603922},{"date":"2024-02-02","current":-6.765239,"twenty":-9.131012,"median":-4.20221,"eighty":-1.078619,"marketCap":530841245},{"date":"2024-02-09","current":-6.635138,"twenty":-9.131012,"median":-4.339366,"eighty":-1.078619,"marketCap":520632759},{"date":"2024-02-16","current":-6.12843,"twenty":-9.131012,"median":-4.37682,"eighty":-1.078619,"marketCap":480873395},{"date":"2024-02-23","current":-6.073651,"twenty":-9.131012,"median":-4.459875,"eighty":-1.082595,"marketCap":476575085},{"date":"2024-03-01","current":-8.285364,"twenty":-9.152685,"median":-4.505594,"eighty":-1.101931,"marketCap":650119339},{"date":"2024-03-08","current":-6.86795,"twenty":-9.152685,"median":-4.658612,"eighty":-1.122353,"marketCap":538900576},{"date":"2024-03-15","current":-6.864526,"twenty":-9.152685,"median":-4.78631,"eighty":-1.163594,"marketCap":538631931},{"date":"2024-03-22","current":-6.237989,"twenty":-9.152685,"median":-4.819439,"eighty":-1.201744,"marketCap":489470014},{"date":"2024-03-28","current":-7.125839,"twenty":-9.152685,"median":-4.887378,"eighty":-1.371955,"marketCap":630259092},{"date":"2024-04-05","current":-7.133855,"twenty":-9.15651,"median":-4.944847,"eighty":-1.549925,"marketCap":630968045},{"date":"2024-04-12","current":-6.733076,"twenty":-9.15651,"median":-4.976853,"eighty":-1.582323,"marketCap":595520402},{"date":"2024-04-19","current":-5.522726,"twenty":-9.15651,"median":-5.010669,"eighty":-1.603058,"marketCap":488468520},{"date":"2024-04-26","current":-5.771208,"twenty":-9.152685,"median":-5.065719,"eighty":-1.622497,"marketCap":510446059},{"date":"2024-05-03","current":-5.763193,"twenty":-9.152685,"median":-5.137904,"eighty":-1.632864,"marketCap":509737106},{"date":"2024-05-10","current":-5.900173,"twenty":-9.152685,"median":-5.17612,"eighty":-1.651056,"marketCap":547341314},{"date":"2024-05-17","current":-6.802306,"twenty":-9.152685,"median":-5.23434,"eighty":-1.663576,"marketCap":631029499},{"date":"2024-05-24","current":-5.648207,"twenty":-9.152685,"median":-5.250196,"eighty":-1.680449,"marketCap":523967191},{"date":"2024-05-31","current":-5.365414,"twenty":-9.152685,"median":-5.252552,"eighty":-1.69118,"marketCap":497733380},{"date":"2024-06-07","current":-5.143766,"twenty":-9.152685,"median":-5.262603,"eighty":-1.719691,"marketCap":477171745},{"date":"2024-06-14","current":-5.05205,"twenty":-9.15651,"median":-5.263947,"eighty":-1.733603,"marketCap":468663482},{"date":"2024-06-21","current":-4.539966,"twenty":-9.160335,"median":-5.26529,"eighty":-1.749497,"marketCap":421159014},{"date":"2024-06-28","current":-4.880081,"twenty":-9.164959,"median":-5.282272,"eighty":-1.761776,"marketCap":452710489},{"date":"2024-07-05","current":-5.044407,"twenty":-9.164959,"median":-5.287002,"eighty":-1.782905,"marketCap":467954460},{"date":"2024-07-12","current":-5.869855,"twenty":-9.164959,"median":-5.307752,"eighty":-1.813296,"marketCap":544528826},{"date":"2024-07-15","current":-6.038002,"twenty":-9.164959,"median":-5.325968,"eighty":-1.814927,"marketCap":560127308},{"date":"2024-08-02","current":-4.654611,"twenty":-9.22331,"median":-5.382384,"eighty":-1.858355,"marketCap":431794343},{"date":"2024-08-09","current":-4.4375,"twenty":-9.22331,"median":-5.382384,"eighty":-1.898763,"marketCap":449722870},{"date":"2024-08-16","current":-4.375927,"twenty":-9.22331,"median":-5.382384,"eighty":-1.922746,"marketCap":443482734},{"date":"2024-08-23","current":-4.740588,"twenty":-9.22331,"median":-5.382384,"eighty":-1.94836,"marketCap":480439628},{"date":"2024-08-30","current":-4.635397,"twenty":-9.22331,"median":-5.382384,"eighty":-1.963276,"marketCap":469778986},{"date":"2024-09-06","current":-4.481118,"twenty":-9.22331,"median":-5.382384,"eighty":-1.992315,"marketCap":454143376},{"date":"2024-09-13","current":-4.97902,"twenty":-9.22331,"median":-5.382384,"eighty":-2.006297,"marketCap":504603752},{"date":"2024-09-20","current":-5.308617,"twenty":-9.22331,"median":-5.392613,"eighty":-2.04582,"marketCap":538007099},{"date":"2024-09-27","current":-4.775651,"twenty":-9.22331,"median":-5.402605,"eighty":-2.071356,"marketCap":483993176},{"date":"2024-10-04","current":-4.312813,"twenty":-9.22331,"median":-5.402605,"eighty":-2.098777,"marketCap":437086348},{"date":"2024-10-11","current":-4.221648,"twenty":-9.22331,"median":-5.402605,"eighty":-2.13584,"marketCap":427847125},{"date":"2024-10-18","current":-4.761626,"twenty":-9.22331,"median":-5.402605,"eighty":-2.165516,"marketCap":482571757},{"date":"2024-10-25","current":-4.744094,"twenty":-9.22331,"median":-5.402605,"eighty":-2.226131,"marketCap":480794983},{"date":"2024-10-31","current":-4.740588,"twenty":-9.22331,"median":-5.402605,"eighty":-2.244588,"marketCap":480439628},{"date":"2024-11-08","current":-5.231477,"twenty":-9.225312,"median":-5.405129,"eighty":-2.271833,"marketCap":530189294},{"date":"2024-11-15","current":-5.809106,"twenty":-9.225312,"median":-5.445898,"eighty":-2.292553,"marketCap":601358704},{"date":"2024-11-22","current":-5.774753,"twenty":-9.225312,"median":-5.463564,"eighty":-2.309931,"marketCap":597802473},{"date":"2024-11-29","current":-5.888119,"twenty":-9.225312,"median":-5.498958,"eighty":-2.31901,"marketCap":609538036},{"date":"2024-12-06","current":-6.279744,"twenty":-9.225312,"median":-5.534802,"eighty":-2.33289,"marketCap":650079072},{"date":"2024-12-13","current":-5.90186,"twenty":-9.225312,"median":-5.583452,"eighty":-2.353729,"marketCap":610960528},{"date":"2024-12-20","current":-5.620165,"twenty":-9.225312,"median":-5.617263,"eighty":-2.367082,"marketCap":581799432},{"date":"2024-12-27","current":-5.496493,"twenty":-9.225312,"median":-5.622268,"eighty":-2.3962,"marketCap":568997000},{"date":"2025-01-03","current":-4.885009,"twenty":-9.225312,"median":-5.622268,"eighty":-2.406198,"marketCap":505696083},{"date":"2025-01-10","current":-5.11861,"twenty":-9.227313,"median":-5.624371,"eighty":-2.432957,"marketCap":529878456},{"date":"2025-01-17","current":-4.610184,"twenty":-9.227313,"median":-5.624371,"eighty":-2.450298,"marketCap":477246233},{"date":"2025-01-24","current":-4.850655,"twenty":-9.227313,"median":-5.624371,"eighty":-2.462386,"marketCap":502139852},{"date":"2025-01-31","current":-4.809432,"twenty":-9.227313,"median":-5.624371,"eighty":-2.492163,"marketCap":497872375},{"date":"2025-02-07","current":-4.747596,"twenty":-9.227313,"median":-5.624371,"eighty":-2.545445,"marketCap":491471158},{"date":"2025-02-14","current":-4.280394,"twenty":-9.227313,"median":-5.624371,"eighty":-2.577061,"marketCap":443106413},{"date":"2025-02-21","current":-4.555219,"twenty":-9.227313,"median":-5.624371,"eighty":-2.609749,"marketCap":471556263},{"date":"2025-02-28","current":-4.886485,"twenty":-9.227313,"median":-5.624371,"eighty":-2.682852,"marketCap":464504340},{"date":"2025-03-07","current":-4.528833,"twenty":-9.229315,"median":-5.62647,"eighty":-2.751011,"marketCap":430506348},{"date":"2025-03-14","current":-4.212868,"twenty":-9.229315,"median":-5.62647,"eighty":-2.800801,"marketCap":400471021},{"date":"2025-03-21","current":-4.682765,"twenty":-9.229315,"median":-5.62647,"eighty":-2.864367,"marketCap":445138943},{"date":"2025-03-28","current":-4.51263,"twenty":-9.229315,"median":-5.62647,"eighty":-2.887636,"marketCap":428966075},{"date":"2025-04-04","current":-3.613344,"twenty":-9.229315,"median":-5.62647,"eighty":-2.950267,"marketCap":343480914},{"date":"2025-04-11","current":-3.370294,"twenty":-9.227313,"median":-5.624371,"eighty":-3.036633,"marketCap":320376817},{"date":"2025-04-17","current":-3.564734,"twenty":-9.227313,"median":-5.624371,"eighty":-3.077604,"marketCap":338860095},{"date":"2025-04-25","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.116395,"marketCap":398160611},{"date":"2025-05-02","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.213748,"marketCap":398160611}],"updateTime":1746269359334}}}